Aclarion, Inc. a healthcare technology company founded on UCSF orthopedic surgeon Jeffery Lotz's research leveraging biomarkers and proprietary algorithms to identify the location of chronic low back pain, announced today that the Company will be participating in the 17th Annual State of Spine Surgery Think Tank in Los Cabos, Mexico, June 22-25, 2022, where it will be presenting 2-year follow up data on its pivotal clinical trial published in the European Spine Journal in 2019. The company will also outline its schedule for the release of an economic analysis report and the initiation of future clinical studies aimed at establishing Nociscan as a standard of care for chronic low back pain.
